Neurogene Inc.
(NASDAQ: NGNE)
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
21.160
+1.040
(+5.17%)
Range
19.890 - 23.001
(15.64%)
Open
20.060
Previous Close
20.120
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
449,778
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
